Vir Biotechnology

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

NEWS ARTICLES

Coalition to Stop Flu Chairman Former Sen. Tom Daschle Quoted in Endpoints News

National Academy of Medicine: “An effective pandemic preparedness and response system is possible”